Cover Image
市場調查報告書

老年性黃斑部病變:全球臨床實驗趨勢

Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 232272
出版日期 內容資訊 英文 489 Pages
訂單完成後即時交付
價格
Back to Top
老年性黃斑部病變:全球臨床實驗趨勢 Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017
出版日期: 2017年03月15日 內容資訊: 英文 489 Pages
簡介

本報告提供全球老年性黃斑部病變治療藥臨床實驗上相關調查,提供各地區,各期,各狀態臨床實驗趨勢,開發中的藥物概要等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上老年性黃斑部病變的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上老年性黃斑部病變的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

老年性黃斑部病變治療藥臨床實驗參與的主要企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017" provides an overview of Age Related Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Age Related Macular Degeneration Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Latest Clinical Trials News on Age Related Macular Degeneration 33
  • Mar 09, 2017: Tyrogenex Completes Patient Enrollment in its Phase 2 Trial of Orally Administered Vorolanib for Wet Age-related Macular Degeneration 33
  • Mar 08, 2017: Opthea Completes FDA Meeting to Inform OPT-302 wet AMD Clinical Program 33
  • Feb 27, 2017: Xbrane Biopharma Reports Positive in-vitro Biosimilarity Data on Xlucane 33
  • Feb 09, 2017: Iconic Therapeutics to Present Phase 2a EMERGE Trial Results at Miami Meeting 34
  • Clinical Trial Profile Snapshots 35

Appendix 486

  • Abbreviations 486
  • Definitions 486
  • Research Methodology 487
  • Secondary Research 487
  • About GlobalData 488
  • Contact Us 488
  • Source 489

List of Tables

List of Tables

  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2017* 15
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2017* 19
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

List of Figures

  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2017* 15
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2017* 18
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 487
Back to Top